Cover Image
市場調查報告書

Von Hippel-Lindau氏症候群:全球臨床實驗檢討

Von Hippel-Lindau Syndrome Global Clinical Trials Review, H2, 2016

出版商 GlobalData 商品編碼 318811
出版日期 內容資訊 英文 42 Pages
訂單完成後即時交付
價格
Back to Top
Von Hippel-Lindau氏症候群:全球臨床實驗檢討 Von Hippel-Lindau Syndrome Global Clinical Trials Review, H2, 2016
出版日期: 2016年09月30日 內容資訊: 英文 42 Pages
簡介

本報告提供Von Hippel-Lindau氏症候群的臨床試驗相關的基本資料和數據,提供您實驗數量及受驗者的募集情況,各階段趨勢,臨床試驗的主要製藥企業及研究機關簡介等資訊。

簡介

  • Von Hippel-Lindau氏症候群
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量

G7各國臨床實驗數量:免疫疾病治療藥臨床實驗上Von Hippel-Lindau氏症候群所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Novartis AG
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Eye Institute
    • National Cancer Institute
    • University of Texas M. D. Anderson Cancer Center
    • National Institute of Neurological Disorders and Stroke
    • Dutch Cancer Society
    • Manhattan Eye Ear & Throat Hospital
    • Association Pour La Recherche des Therapeutiques Innovantes en Cancerologie
    • University Medical Center Groningen
    • Oxford Radcliffe Hospitals NHS Trust
    • Dartmouth-Hitchcock Medical Center

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3797CTIDB

GlobalData's clinical trial report, "Von Hippel-Lindau Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Von Hippel-Lindau Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Von Hippel-Lindau Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 3
  • Report Guidance 4
  • Clinical Trials by Region 5
  • Clinical Trials and Average Enrollment by Country 6
  • Top Countries Contributing to Clinical Trials in Europe 8
  • Top Countries Contributing to Clinical Trials in North America 9
  • Clinical Trials by G7 Countries: Proportion of Von Hippel-Lindau Syndrome to Genetic Disorders Clinical Trials 10
  • Clinical Trials by Phase in G7 Countries 11
  • Clinical Trials in G7 Countries by Trial Status 12
  • Clinical Trials by Phase 13
  • In Progress Trials by Phase 14
  • Clinical Trials by Trial Status 15
  • Clinical Trials by End Point Status 16
  • Subjects Recruited Over a Period of Time 17
  • Clinical Trials by Sponsor Type 18
  • Prominent Sponsors 19
  • Top Companies Participating in Von Hippel-Lindau Syndrome Therapeutics Clinical Trials 20
  • Prominent Drugs 21
  • Clinical Trial Profile Snapshots 22

Appendix 39

  • Abbreviations 39
  • Definitions 39
  • Research Methodology 40
  • Secondary Research 40
  • About GlobalData 41
  • Contact Us 41
  • Disclaimer 41
  • Source 42

List of Tables

  • Von Hippel-Lindau Syndrome Therapeutics, Global, Clinical Trials by Region, 2016* 5
  • Von Hippel-Lindau Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
  • Von Hippel-Lindau Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
  • Von Hippel-Lindau Syndrome Therapeutics Clinical Trials, Europe, Top Countries, 2016* 8
  • Von Hippel-Lindau Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2016* 9
  • Proportion of Von Hippel-Lindau Syndrome to Genetic Disorders Clinical Trials, G7 Countries (%), 2016* 10
  • Von Hippel-Lindau Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 11
  • Von Hippel-Lindau Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 12
  • Von Hippel-Lindau Syndrome Therapeutics, Global, Clinical Trials by Phase, 2016* 13
  • Von Hippel-Lindau Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 14
  • Von Hippel-Lindau Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2016* 15
  • Von Hippel-Lindau Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2016* 16
  • Von Hippel-Lindau Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 17
  • Von Hippel-Lindau Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 18
  • Von Hippel-Lindau Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 19
  • Von Hippel-Lindau Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 20
  • Von Hippel-Lindau Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 21

List of Figures

  • Von Hippel-Lindau Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2016* 5
  • Von Hippel-Lindau Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
  • Von Hippel-Lindau Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
  • Von Hippel-Lindau Syndrome Therapeutics Clinical Trials, Europe, Top Countries (%), 2016* 8
  • Proportion of Von Hippel-Lindau Syndrome to Genetic Disorders Clinical Trials, G7 Countries (%), 2016* 10
  • Von Hippel-Lindau Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 11
  • Von Hippel-Lindau Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 12
  • Von Hippel-Lindau Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2016* 13
  • Von Hippel-Lindau Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 14
  • Von Hippel-Lindau Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2016* 15
  • Von Hippel-Lindau Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2016* 16
  • Von Hippel-Lindau Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 17
  • Von Hippel-Lindau Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 18
  • Von Hippel-Lindau Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 19
  • Von Hippel-Lindau Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 20
  • Von Hippel-Lindau Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 21
  • GlobalData Methodology 40
Back to Top